| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 113, 1726-1731, Copyright © 1983 by Endocrine Society
ARTICLES |
LM Bilezikjian and WW Vale
The stimulation of GH secretion from the anterior pituitary by synthetic GRF (hpGRF) is associated with a rapid increase in cAMP production. Within 5 min of the addition of 1 nM hpGRF to cultured rat anterior pituitary cells, intracellular cAMP levels are elevated 6- fold, with a maximal response being observed at 30 min. cAMP accumulation in the extracellular medium is also enhanced by this peptide. Comparison of the two cellular responses (GH secretion and cAMP formation) at various concentrations of hpGRF indicates that 10 times more hpGRF is required to obtain half-maximal stimulation of cAMP production than for GH secretion. Somatostatin totally blocks hpGRF- stimulated GH release, but only partially attenuates cAMP production in the presence or absence of a phosphodiesterase inhibitor. Verapamil also inhibits GH release in response to hpGRF, but, unlike somatostatin, this effect is not associated with an attenuation of cAMP production. In fact, intracellular cAMP levels are slightly augmented in the presence of verapamil, indicating that Ca2+ is required for hormone release but not for the activation of adenylate cyclase. Consistent with this is the observation that the release of GH due to 8- bromo-cAMP is also blocked by verapamil. A requirement for Ca2+ is further indicated by the inhibitory effects of CoCl2 and CdCl2 on both basal and hpGRF-stimulated GH release. These results suggest that cAMP may play a role as an intracellular mediator of GRF action in somatotrophs and that Ca2+ is required for the release process. Somatostatin may exert its inhibitory effects on GH secretion either by interfering with cAMP production or by an action on the secretory process subsequent to cAMP production.
This article has been cited by other articles:
![]() |
K. Bedard, J. Strecko, K. Theriault, J. Bedard, C. Veyrat-Durebex, and P. Gaudreau Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E740 - E751. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsaneva-Atanasova, A. Sherman, F. van Goor, and S. S. Stojilkovic Mechanism of Spontaneous and Receptor-Controlled Electrical Activity in Pituitary Somatotrophs: Experiments and Theory J Neurophysiol, July 1, 2007; 98(1): 131 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. S. Frutos, L. Cacicedo, C. F. Mendez, D. Vicent, M. Gonzalez, and F. Sanchez-Franco Pituitary Alterations Involved in the Decline of Growth Hormone Gene Expression in the Pituitary of Aging Rats J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2007; 62(6): 585 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Yunker, S. Smith, C. Graves, P. J. Davis, S. Unniappan, J. E. Rivier, R. E. Peter, and J. P. Chang Endogenous Hypothalamic Somatostatins Differentially Regulate Growth Hormone Secretion from Goldfish Pituitary Somatotropes in Vitro Endocrinology, September 1, 2003; 144(9): 4031 - 4041. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boisvert, C. Pare, C. Veyrat-Durebex, A. Robert, S. Dubuisson, G. Morel, and P. Gaudreau Localization and Regulation of a Functional GHRH Receptor in the Rat Renal Medulla Endocrinology, April 1, 2002; 143(4): 1475 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Negishi, C. L. Chik, and A. K. Ho Ceramide Enhances Growth Hormone (GH)-Releasing Hormone-Stimulated Cyclic Adenosine 3',5'-Monophosphate Accumulation but Inhibits GH Release in Rat Anterior Pituitary Cells Endocrinology, December 1, 1999; 140(12): 5691 - 5697. [Abstract] [Full Text] |
||||
![]() |
N. Girard, L. Boulanger, S. Denis, and P. Gaudreau Differential in Vivo Regulation of the Pituitary Growth Hormone-Releasing Hormone (GHRH) Receptor by GHRH in Young and Aged Rats Endocrinology, June 1, 1999; 140(6): 2836 - 2842. [Abstract] [Full Text] |
||||
![]() |
J. Yasufuku-Takano, K. Takano, T. Takei, S. Fukumoto, A. Teramoto, K. Takakura, N. Yamashita, and T. Fujita Heterozygous gsp Mutation Renders Ion Channels of Human Somatotroph Adenoma Cells Unresponsive to Growth Hormone-Releasing Hormone Endocrinology, May 1, 1999; 140(5): 2018 - 2026. [Abstract] [Full Text] |
||||
![]() |
J. L. Ramírez, J. P. Castaño, R. Torronteras, A. J. Martínez-Fuentes, L. S. Frawley, S. García-Navarro, and F. Gracia-Navarro Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations Endocrinology, April 1, 1999; 140(4): 1752 - 1759. [Abstract] [Full Text] |
||||
![]() |
J. P. Moore Jr., A. Cai, B. E. Maley, L. Jennes, and J. F. Hyde Galanin within the Normal and Hyperplastic Anterior Pituitary Gland: Localization, Secretion, and Functional Analysis in Normal and Human Growth Hormone-Releasing Hormone Transgenic Mice Endocrinology, April 1, 1999; 140(4): 1789 - 1799. [Abstract] [Full Text] |
||||
![]() |
E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takei, J. Yasufuku-Takano, K. Takano, T. Fujita, and N. Yamashita Effect of Ca2+ and cAMP on capacitance-measured hormone secretion in human GH-secreting adenoma cells Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E649 - E654. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Isumi, N. Minamino, T. Katafuchi, M. Yoshioka, T. Tsuji, K. Kangawa, and H. Matsuo Adrenomedullin Production in Fibroblasts: Its Possible Function as a Growth Regulator of Swiss 3T3 Cells Endocrinology, May 1, 1998; 139(5): 2552 - 2563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kato and Y. Sakuma Regulation by Growth Hormone-Releasing Hormone and Somatostatin of a Na+ Current in the Primary Cultured Rat Somatotroph Endocrinology, December 1, 1997; 138(12): 5096 - 5100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kirk, B. J. Gertz, S. H. Schneider, M. L. Hartman, S. S. Pezzoli, J. M. Wittreich, D. A. Krupa, J. R. Seibold, and M. O. Thorner Effect of Obesity and Feeding on the Growth Hormone (GH) Response to the GH Secretagogue L-692,429 in Young Men J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1154 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schaufele and F. Schaufele CCAAT/Enhancer-binding Protein alpha Activation of the Rat Growth Hormone Promoter in Pituitary Progenitor GHFT1-5 Cells J. Biol. Chem., August 30, 1996; 271(35): 21484 - 21489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Castrillo, L. Theill, and M Karin Function of the homeodomain protein GHF1 in pituitary cell proliferation Science, July 12, 1991; 253(5016): 197 - 199. [Abstract] [PDF] |
||||
![]() |
J. Jansson, T. Downs, W. Beamer, and L. Frohman Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice Science, April 25, 1986; 232(4749): 511 - 512. [Abstract] [PDF] |
||||
![]() |
S. Pandol, H Seifert, M. Thomas, J Rivier, and W Vale Growth hormone-releasing factor stimulates pancreatic enzyme secretion Science, July 20, 1984; 225(4659): 326 - 328. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |